Navigation Links
Assessing positive outcomes of phase III trials
Date:12/3/2010

Randomized phase III studies should be designed to find out whether a new drug or treatment makes a meaningful difference in patients' survival or quality of life, according to a commentary published online December 3rd in The Journal of the National Cancer Institute. Instead, most trials now are designed to detect a statistically significant difference between treatment and control groups, which may not be clinically meaningful, write Alberto Ocana, M.D., Ph.D. and Ian F. Tannock, M.D., Ph.D., of Princess Margaret Hospital in Toronto.

Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA) approve drugs usually based on statistically significant results of randomized phase III trials comparing a new, investigational drug with standard treatment. Ocana and Tannock note that pharmaceutical companies have typically sponsored clinical trials that are large enough to detect statistically significant differences in survival. But these differences are often trivial, they say. For instance, the trial that led to approval of erlotinib (Tarceva) for pancreatic cancer found that patients who took the drug had a median survival just 10 days longer than patients in the control group. However, the difference was statistically significant, and the drug was approved.

The authors write that pharmaceutical companies look for a difference in survival outcome between two groups of a trial that is "not usually the minimal difference in overall survival or progression-free survival that is clinically important, but more likely the minimal difference that is feasible to detect, considering the limits on the sample size and hence the cost of the trial."

The authors argue for another approach: "Ideally, trials should be designed [to detect] the minimum clinically important difference, taking into account the tolerability and toxicity of the new treatment, that would persuade oncologists to adop
'/>"/>

Contact: Kristine Crane
jncimedia@oxfordjournals.org
301-841-1285
Journal of the National Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers validate a new test for assessing childrens and teenagers fitness to prevent morbidity
2. Assessing the science behind health claims
3. For HIV-positive patients, delayed treatment a costly decision
4. Positive Attitude, Planning May Help Women Through Menopause
5. Positive psychological changes from meditation training linked to cellular health
6. Positive social traits trump bad health habits
7. Targeted therapy promising for HER2-positive metastatic breast cancer
8. New study finds positive return on investment for states that invest in quit smoking treatments
9. Study shows tranquil scenes have positive impact on brain
10. Survey of American women finds STD vaccine viewed positively
11. Penns Positive Psychology Center awards $2.9 million for research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ... 03, 2015 , ... According to an opinion piece published July 28 by the ... one pound of weight loss may not be accurate. While this system may work for ... of fat varies – based both on the individual and at what point that person ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... diseases researchers from the University of Pittsburgh School of Medicine are leading a ... prevention drugs in sub-Saharan Africa. , A cooperative agreement awarded by the ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... fitness site and the largest online retailer of nutritional supplements, has officially ... is up for 11 awards in the following categories:, ...
(Date:8/3/2015)... TAMPA, Florida (PRWEB) , ... August 03, 2015 ... ... Association for Physician Leadership ® and Navigant Center for Healthcare Research and Policy ... nationwide. , Fifty-five percent of respondents said they agreed or strongly agreed that ...
(Date:8/3/2015)... ... 2015 , ... A July 9 article from USA Today has ... to the American Dental Association. According to a study by the American Dental Association, ... in a single year to 2.2 million a year. Dentists and ADA officials all ...
Breaking Medicine News(10 mins):Health News:Article Dispelling Weight Loss Myth Correctly Emphasizes the Complicated and Difficult Nature of Weight Loss, Says Dr. Michael Feiz 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 2Health News:Los Angeles Periodontists Comment on Rising Dental Emergency Room Trips 3
... VEGAS, Oct. 7 Cord Blood America, Inc. (OTC Bulletin ... ( http://www.cordblood-america.com ) focused on bringing the ... to families nationwide and internationally, said today that it has ... the third quarter of 2009. Total debt eliminated in ...
... The Ensign Group, Inc. (Nasdaq: ENSG ), announced ... skilled nursing and independent living campus, as well as ... acquisition was effective October 1, 2009. , (Logo: ... existing operational base and broaden our service offerings in ...
... LONDON and WASHINGTON, Oct. 7 Tranziger Limited announced ... team to advise and assess companies in the life ... realise and optimise value from their portfolios in these ... UK and has offices in Washington, DC and Edinburgh. ...
... ... Flexible Hypervisor Technologies Managed by Unified Set of Automation Tools Enable Profitable Cloud Services ... ... leader, Parallels , today announced enhancements to its server virtualization product portfolio to ...
... ... security landscape, endpoint security, and IT GRC with industry leaders , ... Scottsdale, AZ (PRWEB) October 7, 2009 -- As cybercrime ... organizations are faced with the challenge of staying ahead of these threats. To enable ...
... ... cancer research and support foundation. , ... Hampton Roads, Va. (PRWEB) October 7, 2009--October is breast cancer awareness month. Customer Magnetism, ... of funds from all new contracts signed and received during this month toward breast cancer ...
Cached Medicine News:Health News:Cord Blood America Announces Debt Reduction Tally: $8.7 Million in 2009; $3.7 Million in Third Quarter 2Health News:The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 2Health News:The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 3Health News:Tranziger Announces Formation of Global Advisory & Development Team 2Health News:Tranziger Announces Formation of Global Advisory & Development Team 3Health News:Parallels Server Bare Metal Launches, Building on Parallels' Containers Leadership to Enable Cloud Services Providers to Extend Virtualized Services 2Health News:Parallels Server Bare Metal Launches, Building on Parallels' Containers Leadership to Enable Cloud Services Providers to Extend Virtualized Services 3Health News:Parallels Server Bare Metal Launches, Building on Parallels' Containers Leadership to Enable Cloud Services Providers to Extend Virtualized Services 4Health News:Parallels Server Bare Metal Launches, Building on Parallels' Containers Leadership to Enable Cloud Services Providers to Extend Virtualized Services 5Health News:Lumension Launches New Optimal IT Security Videocast Series 2Health News:Lumension Launches New Optimal IT Security Videocast Series 3Health News:Customer Magnetism Donates Funds In Support Of Breast Cancer Research 2Health News:Customer Magnetism Donates Funds In Support Of Breast Cancer Research 3
(Date:8/3/2015)... -- Sage Analytics ( www.sageanalytics.com ), the developers of a ... announced its sponsorship of the California Cannabis Industry Association ... of tickets are available for groups or individuals to ... enjoying an open bar, buffet dinner and hors d,oeuvres, ... at sunset. With the legislative session in ...
(Date:8/3/2015)... , August 3, 2015 ... expected to reach USD 24.7 billion by 2022, ... Research Inc. Growing prevalence of neurological and musculoskeletal ... market over the forecast period. The presence of ... cryotherapy, advancement in the technologies coupled with implementation ...
(Date:8/3/2015)... SINGAPORE , Aug. 3, 2015 ... Bloomberg: BIG SP; Reuters: BIOS.SI; SGX: B20), a ... today announced financial results for its first fiscal ... Quarter Highlights and Recent Developments: ... progress in improving its cost structure, driven by ...
Breaking Medicine Technology:Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 2Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 3Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 4Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 5Biosensors Reports Financial Results for the First Quarter of Fiscal Year 2016 6
... COLLEGEVILLE, Pa., May 30 Wyeth,Pharmaceuticals, a ... today announced the,initiation of the INTORACT (INvestigation ... worldwide randomized, open-label, phase 3b,study comparing TORISEL(R) ... for first-line treatment of patients,with advanced renal ...
... INC. (Nasdaq: VION ) today announced that ... agent Cloretazine(R) (VNP40101M) in,acute myelogenous leukemia (AML) would ... of Clinical Oncology (ASCO(R)) Annual Meeting in Chicago,Illinois., ... blind placebo-controlled,randomized phase III study of high-dose continuous ...
Cached Medicine Technology:Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 2Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 3Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 4Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 5Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 6Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals to Present Clinical Data on Cloretazine(R) (VNP40101M) at the ASCO(R) Annual Meeting 3
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
Medicine Products: